PURL
(728 K)
Title:
EVALUATION OF RADIOBIOLGICAL EFFECTS OF NEGATIVE PI MESONS ON MISCELLANEOUS METASTATIC LESIONS
Subject Terms:
HREX; CANCER; CLINICAL; HISTORY - GENERAL; HUMAN; PATIENT; PION; PION RADIOTHERAPY; THERAPY
Document Location:
Location - DOE/NNSA NUCLEAR TESTING ARCHIVE Address - P.O. Box 98521 City - Las Vegas State - NV Zip - 89193-8521 Phone - (702)794-5106 Fax - (702)862-4240 Email - NTA@NV.DOE.GOV
Publication Date:
1979 Oct 30
Declassification Status:
Never classified
Accession Number:
NV0712842
OpenNet Entry Date:
1995 Feb 17
OpenNet Modified Date:
2017 Dec 21
Description/Abstract:
THIS DOCUMENT IS A PROTOCOL FOR HUMAN RADIOBIOLOGY STUDIES OF THE PI MESON RADIATION THERAPY AT THE UNIVERSITY OF NEW MEXICO/LOS ALAMOS SCIENTIFIC LABORATORY. ELIGIBLE PATIENTS MUST HAVE METASTATIC LESIONS ORIGINATING FROM BIOPSY-PROVEN SOLID TUMORS, WHOSE PROJECTED SURVIVAL AT LEAST THREE MONTHS. ALL PATIENTS WILL RECEIVE NON-RANDOMIZED PION THERAPY AT THE MESON PHYSICS FACILITY (LAMPF) IN LOS ALAMOS EITHER ALO OR AS A PLANNED BOOST IN CONJUNCTION WITH CONVENTIONAL RADIOTHERAPY. CURRENT TREATMENT POLICY FOR TREATMENT OF PELVIS, HEAD AND NECK, BRAIN AND PANCREAS SITES ARE LISTED. PATENT CONSENT FORMS ARE INCLUDED, SOM FOR BOTH MALE AND FEMALE PATIENTS.